Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
AKTIENPREIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership621,935 shares
Latest Disclosed Value $ 20,567,390
Qube Research & Technologies Ltd reports 131.86% increase in ownership of 354 / Collegium Pharmaceutical, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 621,935 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $17,165,406 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 268,242 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 131.86% during the quarter. The current value of the position is $16,170,310 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 621,935 353,693 131.86 20,567 65.61 0.0229
2026-02-17 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 268,242 -52,317 -16.32 12,420 10.73 0.0126
2025-11-14 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 320,559 225,679 237.86 11,216 299.86 0.0116
2025-08-14 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 94,880 41,315 77.13 2,806 75.53 0.0029
2025-05-15 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 53,565 -164,248 -75.41 1,599 -74.39 0.0019
2025-02-14 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 217,813 149,666 219.62 6,240 136.99 0.0082
2024-11-14 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 68,147 13,691 25.14 2,633 50.20 0.0039
2024-08-14 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 54,456 54,456 1,753 0.0028
2024-05-14 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -16,001 -100.00 0 -100.00
2024-02-13 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 16,001 -111,009 -87.40 493 -82.66 0.0010
2023-11-13 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 127,010 111,394 713.33 2,839 747.16 0.0074
2023-08-14 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 15,616 -19,348 -55.34 336 -60.02 0.0012
2023-05-15 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 34,964 34,964 839 0.0036
2022-08-15 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -19,699 -100.00 0 -100.00
2022-05-09 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 19,699 -62,177 -75.94 401 -73.77 0.0034
2022-02-10 2021-12-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 81,876 55,581 211.37 1,529 194.61 0.0118
2022-02-01 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 81,876 55,581 1,529 0.0118
2021-11-12 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 26,295 8,280 45.96 519 21.83 0.0065
2021-08-13 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 18,015 -1,844 -9.29 426 -9.55 0.0049
2021-05-14 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 19,859 -5,096 -20.42 471 -5.80 0.0075
2021-02-16 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 24,955 24,955 500 0.0071
2020-05-15 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 0 -19,708 -100.00 0 -100.00
2020-02-13 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 19,708 19,708 406 0.0127
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.